Status:
COMPLETED
Effects of a Comprehensive Patient-centered Health Service in Cystic Fibrosis (VEMSE-CF)
Lead Sponsor:
Mukoviszidose Institut gGmbH
Collaborating Sponsors:
Federal Ministry of Health, Germany
Wuerzburg University Hospital
Conditions:
Cystic Fibrosis
Eligibility:
All Genders
5+ years
Phase:
NA
Brief Summary
For the Project VEMSE-CF, a comprehensive patient-centered outpatient health service model was developed offering focused interventions in different areas. These included patient education, as well as...
Eligibility Criteria
Inclusion
- confirmed diagnosis of Cystic Fibrosis - written informed consent
- intervention group: care in one of the 3 CF-centers
- control group: care in one of the 13 control CF-centers
Exclusion
- post lung Transplantation
- listed for lung Transplantation and planned inpatient stay for more than 4 weeks
Key Trial Info
Start Date :
August 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 31 2016
Estimated Enrollment :
318 Patients enrolled
Trial Details
Trial ID
NCT03423576
Start Date
August 1 2011
End Date
December 31 2016
Last Update
February 19 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Mukoviszidose Institut
Bonn, Germany, 53117